BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
BIO KEY INTERNATIONAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.27−0.36 (-13.69%)
Close on Oct 19, 2026
- Market cap
- $2.35M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.03 (−68.91%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
BIO KEY INTERNATIONAL INC saw revenue fall 3.1% to $6.70M over the twelve months to Jun 30, 2026. Free cash flow was -$4.16M.
Revenue
$6.70M
-3.1% vs. a year earlier
Operating income
-$5.79M
TTM Q2 2026
Free cash flow
-$4.16M
TTM Q2 2026
EPS, diluted
-$6.82
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.35M
- P/E ratio
- –
- Price to sales
- 0.35
- Price to book
- 0.54
- Dividend yield
- –
- Free cash flow yield
- -176.83%
Fundamentals
- Revenue
- $6.70M
- Net income
- -$6.04M
- EPS, diluted
- -$6.82
- Free cash flow
- -$4.16M
- Book value per share
- $4.18
- Diluted shares
- 1M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$6.70M-3.1% YoY
Gross profit
$5.45M+0.1% YoY
Operating income
-$5.79M
Net income
-$6.04M
EPS, diluted
-$6.82
Free cash flow
-$4.16M
Reported periodTrailing twelve months